Vycor Medical Statistics
Total Valuation
Vycor Medical has a market cap or net worth of 3.67 million. The enterprise value is 4.64 million.
| Market Cap | 3.67M |
| Enterprise Value | 4.64M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vycor Medical has 33.37 million shares outstanding. The number of shares has increased by 2.07% in one year.
| Current Share Class | 33.37M |
| Shares Outstanding | 33.37M |
| Shares Change (YoY) | +2.07% |
| Shares Change (QoQ) | -13.69% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | n/a |
| Float | 12.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.93 |
| PB Ratio | -0.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.68, with an EV/FCF ratio of -49.69.
| EV / Earnings | -13.62 |
| EV / Sales | 2.44 |
| EV / EBITDA | 19.68 |
| EV / EBIT | 51.72 |
| EV / FCF | -49.69 |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.39 |
| Debt / FCF | -11.09 |
| Interest Coverage | 0.87 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.57% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -2.32% |
| Weighted Average Cost of Capital (WACC) | 3.86% |
| Revenue Per Employee | 271,678 |
| Profits Per Employee | -48,692 |
| Employee Count | 7 |
| Asset Turnover | 1.89 |
| Inventory Turnover | 1.57 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +95.99% in the last 52 weeks. The beta is -0.28, so Vycor Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | +95.99% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 41.77 |
| Average Volume (20 Days) | 29,258 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, Vycor Medical had revenue of 1.90 million and -340,847 in losses. Loss per share was -0.01.
| Revenue | 1.90M |
| Gross Profit | 1.62M |
| Operating Income | 89,769 |
| Pretax Income | -14,496 |
| Net Income | -340,847 |
| EBITDA | 153,637 |
| EBIT | 89,769 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 64,230 in cash and 1.04 million in debt, with a net cash position of -971,572 or -0.03 per share.
| Cash & Cash Equivalents | 64,230 |
| Total Debt | 1.04M |
| Net Cash | -971,572 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -4.02M |
| Book Value Per Share | -0.12 |
| Working Capital | -4.15M |
Cash Flow
In the last 12 months, operating cash flow was -90,984 and capital expenditures -2,450, giving a free cash flow of -93,434.
| Operating Cash Flow | -90,984 |
| Capital Expenditures | -2,450 |
| Free Cash Flow | -93,434 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 85.35%, with operating and profit margins of 4.72% and -0.87%.
| Gross Margin | 85.35% |
| Operating Margin | 4.72% |
| Pretax Margin | -0.76% |
| Profit Margin | -0.87% |
| EBITDA Margin | 8.08% |
| EBIT Margin | 4.72% |
| FCF Margin | n/a |
Dividends & Yields
Vycor Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.07% |
| Shareholder Yield | -2.07% |
| Earnings Yield | -9.28% |
| FCF Yield | -2.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2013. It was a reverse split with a ratio of 0.0066666.
| Last Split Date | Jan 15, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.0066666 |
Scores
Vycor Medical has an Altman Z-Score of -52.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -52.48 |
| Piotroski F-Score | 4 |